Filgrastim biosimilar (Raichem Lifesciences)

非格司亭生物类似药（Raichem Lifesciences）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Raichem Lifesciences)

Drug Alias NamerhG-CSF (Raichem Lifesciences)非格司亭生物仿制药（Raichem Lifesciences）Recombinant human granulocyte macrophage colony stimulating factor (Raichem Lifesciences)重组人粒细胞刺激因子（Raichem Lifesciences）

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesRaichem Lifesciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRaichem Lifesciences

Active IndicationsN/A

Inactive IndicationsNeutropenia

Other Information

ATC CodeL03AA02